open access

Vol 4, No 2 (2001)
Short communications
Published online: 2001-07-23
Submitted: 2012-01-23
Get Citation

Are CSF neopterin levels a marker of disease activity in multiple sclerosis?

Kostas Kapinas Magda Tsolaki, Demetrios Zaphiriou, Philip Grammaticos, Eleni Dedussi
Nucl. Med. Rev 2001;4(2):109-112.

open access

Vol 4, No 2 (2001)
Short communications
Published online: 2001-07-23
Submitted: 2012-01-23

Abstract

The study aimed to evaluate neopterin levels in cerebro-spinal fluid (CSF) as a marker of disease activation and progression of multiple sclerosis (MS). Neopterin, a substance known to be released from macrophages and monocytes at increased rates in cellular immune reactions, was investigated by radioimmunoassay, in the CSF of 19 patients with MS during exacerbations of the disease, in 34 patients with other neurological diseases (OND) and in 20 normal subjects used as controls. Poser's criteria were used for the diagnosis of MS. Although elevated neopterin levels in the CSF of patients with MS during exacerbations have been reported by other investigators, we found such elevation in only 4 out of 19 patients with MS (21%), in 5 out of 34 patients with OND (14.7%), and in none of the control group. Student's t-test was used for statistical analysis. There was no significant difference in the CSF values of the MS patients, the patients with OND (p > 0.05) or the controls. These results indicate that neopterin levels in CSF may not be considered a marker of disease activity in MS.

Abstract

The study aimed to evaluate neopterin levels in cerebro-spinal fluid (CSF) as a marker of disease activation and progression of multiple sclerosis (MS). Neopterin, a substance known to be released from macrophages and monocytes at increased rates in cellular immune reactions, was investigated by radioimmunoassay, in the CSF of 19 patients with MS during exacerbations of the disease, in 34 patients with other neurological diseases (OND) and in 20 normal subjects used as controls. Poser's criteria were used for the diagnosis of MS. Although elevated neopterin levels in the CSF of patients with MS during exacerbations have been reported by other investigators, we found such elevation in only 4 out of 19 patients with MS (21%), in 5 out of 34 patients with OND (14.7%), and in none of the control group. Student's t-test was used for statistical analysis. There was no significant difference in the CSF values of the MS patients, the patients with OND (p > 0.05) or the controls. These results indicate that neopterin levels in CSF may not be considered a marker of disease activity in MS.
Get Citation

Keywords

multiple sclerosis; neopterin; cerebro-spinal fluid

About this article
Title

Are CSF neopterin levels a marker of disease activity in multiple sclerosis?

Journal

Nuclear Medicine Review

Issue

Vol 4, No 2 (2001)

Pages

109-112

Published online

2001-07-23

Bibliographic record

Nucl. Med. Rev 2001;4(2):109-112.

Keywords

multiple sclerosis
neopterin
cerebro-spinal fluid

Authors

Kostas Kapinas Magda Tsolaki
Demetrios Zaphiriou
Philip Grammaticos
Eleni Dedussi

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl